PAX8 Polyclonal antibody
PAX8 Polyclonal Antibody for ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human and More (1)
Applications
IF, ELISA
Conjugate
Unconjugated
Cat no : 21384-1-AP
Synonyms
Validation Data Gallery
Published Applications
IF | See 1 publications below |
Product Information
The immunogen of 21384-1-AP is PAX8 Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Cited Reactivity | human, mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | PAX8 fusion protein Ag16019 |
Full Name | paired box 8 |
Calculated Molecular Weight | 450 aa, 48 kDa |
GenBank Accession Number | BC001060 |
Gene Symbol | PAX8 |
Gene ID (NCBI) | 7849 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PAX8 is a member of the paired box (PAX) family of transcription factors, typically containing a paired box domain and a paired-type homeodomain. The specific function of the PAX8 is unknown but it may involve kidney cell differentiation, thyroid development, or thyroid dysgenesis. Several other splice variants have been proposed but the full nature of these products has not been described. Pax8 is also a marker of otic progenitor cells. PAX8 is a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. PAX8 can be used in a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. Mutation of PAX8 will cause congenital hypothyroidism non-goitrous type 2 (CHNG2). This antibody is specific to Pax8.
Publications
Species | Application | Title |
---|---|---|
Sci Rep Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium. | ||
Cell Rep Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis. |